These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29635720)

  • 1. Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis.
    Safiri S; Sullman MJM; Ayubi E
    Acta Neurol Scand; 2018 May; 137(5):538. PubMed ID: 29635720
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to the letter to the Editor: Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis. Safiri S et al.
    Spataro R; Volanti P; Lo Coco D; La Bella V
    Acta Neurol Scand; 2018 May; 137(5):539. PubMed ID: 29635719
    [No Abstract]   [Full Text] [Related]  

  • 3. Marital status is a prognostic factor in amyotrophic lateral sclerosis.
    Spataro R; Volanti P; Lo Coco D; La Bella V
    Acta Neurol Scand; 2017 Dec; 136(6):624-630. PubMed ID: 28470818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis in amyotrophic lateral sclerosis: a population-based study.
    Chiò A; Mutani R; Mora G
    Neurology; 2003 Dec; 61(12):1826-7; author reply 1827. PubMed ID: 14694066
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.
    Jésus P; Fayemendy P; Nicol M; Lautrette G; Sourisseau H; Preux PM; Desport JC; Marin B; Couratier P
    Eur J Neurol; 2018 Jan; 25(1):97-104. PubMed ID: 28940704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place of death and associated factors among patients with amyotrophic lateral sclerosis in Madrid (Spain).
    Domínguez-Berjón MF; Esteban-Vasallo MD; Zoni AC; Gènova-Maleras R; Astray-Mochales J
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):62-8. PubMed ID: 26473583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of amyotrophic lateral sclerosis and their prognostic value.
    Tard C; Defebvre L; Moreau C; Devos D; Danel-Brunaud V
    Rev Neurol (Paris); 2017 May; 173(5):263-272. PubMed ID: 28477850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motor neuron disease: primary lateral sclerosis and amyotrophic lateral sclerosis].
    Martić V
    Vojnosanit Pregl; 2000; 57(2):205-8. PubMed ID: 10934934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis.
    D'Ovidio F; d'Errico A; Carnà P; Calvo A; Costa G; Chiò A
    Eur J Neurol; 2018 Jan; 25(1):164-170. PubMed ID: 28921834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the duration of Guam amyotrophic lateral sclerosis.
    Reed DM; Brody JA; Holden EM
    Neurology; 1975 Mar; 25(3):277-80. PubMed ID: 1167636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rate of amyotrophic lateral sclerosis in Japan: effects of marital status and social class, and geographical variation.
    Imaizumi Y
    Jinrui Idengaku Zasshi; 1986 Jun; 31(2):101-11. PubMed ID: 3820769
    [No Abstract]   [Full Text] [Related]  

  • 13. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis.
    Roubeau V; Blasco H; Maillot F; Corcia P; Praline J
    Muscle Nerve; 2015 Apr; 51(4):479-84. PubMed ID: 25130859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
    Vucic S
    Eur J Neurol; 2018 Jan; 25(1):1-2. PubMed ID: 28940741
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Amyotrophic lateral sclerosis: Ongoing search for prognostic biomarkers of longevity.
    Pandey S; Sarma N
    Neurol India; 2017; 65(5):1155-1156. PubMed ID: 28879922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic factors in amyotrophic lateral sclerosis].
    Ramelli E
    Acta Neurol (Napoli); 1970; 25(4):441-9. PubMed ID: 5505433
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis in amyotrophic lateral sclerosis: a population-based study.
    del Aguila MA; Longstreth WT; McGuire V; Koepsell TD; van Belle G
    Neurology; 2003 Mar; 60(5):813-9. PubMed ID: 12629239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
    Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2002; (3):CD002064. PubMed ID: 12137643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histopathology of the central nervous system in amyotrophic lateral sclerosis. III. Inflammatory factor of amyotrophic lateral sclerosis].
    KHONDKARIAN OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1955; 55(10):755-8. PubMed ID: 13300956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.